(ISSN 2573-4407)
OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 7.5 weeks; Submission to Acceptance: 15.9 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
Current Trends in the Diagnosis and Management of Neuroleptic Malignant Syndrome
Submission Deadline: March 31, 2023 (Open) Submit Now
Guest Editor
Dr. Varadaraj Velamoor,
1. Professor of Psychiatry, Lakehead and Laurentian University, Canada
2. Professor Emeritus, Western University, Canada
3. Dr Velamoor has published over a hundred publications including book chapters and monographs. His work in the early diagnosis and management of Neuroleptic Malignant Syndrome in internationally recognized.
Research interests: suicide, violence, collaborative care, and traumatic brain injury; diagnosis of neuroleptic malignant syndrome
About This Topic
Neuroleptic Malignant Syndrome remains a dangerous condition with high morbidity and mortality. Although we now have a better understanding of the early diagnosis and management of this neurological disorder, we need to focus on the etiopathology to develop sound protocols for diagnosis and management. Emphasis on pharmacological and environmental variables with appropriate blood work and imaging standards will lead to safer outcomes for patients suspected of this diagnosis. We need to educate mental health care givers in better recognition and monitoring approaches to improve care and service to their patients.
This special issue is dedicated to focus on new advances and treatment by experts in the field. Their contributions will throw fresh light on this disorder and enable practitioners to gain confidence in their ability to understand and treat this condition safely.
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (neurobiology@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
- Journal Metrics
-
2023 
CiteScore SJR SNIP 1.0 0.232 0.256 - Newsletter